IVD Technology
Articles by Category - Assay Development
2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002
Note: To order an article reprint, or back issue, please contact the Canon Bookstore at 310/445-3770, or send E-mail to bookstore@devicelink.com. For faster service, fax your request, along with your telephone number, to 310/445-4259. Volume discounts are available.
2008
- (Assay Development) Recombinant autoantigens: Reliable targets in autoimmune IVDs, Bodo Liedvogel, Heinz Haubruck, and Richard Kneusel (IVDT, Jun 2008, p. 51).
- (Assay Development) Detecting metabolic changes in diabetes mellitus, Sergei Khartchenko and Nigel Flook (IVDT, May 2008, p. 49).
- (Assay Development) Developing nanotechnology-based protein detection, James J. Storhoff, Michael J. Senical, and William H. Cork (IVDT, Apr 2008, p. 41).
- (Assay Development) Value of purified native autoantigens in IVDs, Richard Park (IVDT, Mar 2008, p. 37).
- (Assay Development) Membranes and solid phase matrices for sample preparation, Kevin D. Jones and Betsy Moran (IVDT, Mar 2008, p. 31).
- (Editor's Page) Assays are here to stay, Richard Park (IVDT, Mar 2008, p. 8).
- (Assay Development) Comparing statistical analysis methods for diagnostic devices, Roger F. Sewell and Amanda J. Fuller (IVDT, Jan 2008, p. 47).
2007
- (Assay Development) Dissolvable films and their potential in IVDs, William Meathrel and Cathy Moritz (IVDT, Nov 2007, p. 53). Keywords: Assay Development.
- (Assay Development) An ELISA for determining aspirin effect from urine, F. Jon Geske, Ivana J. Muncy, Luis R. Lopez, and Daniel J. Tew (IVDT, Jul 2007, p. 55).
- (Assay Development) Diagnostic challenges in traumatic brain injury, Svetlana A. Dambinova (IVDT, Mar 2007, p. 41).
- (Assay Development) Microparticle technology in clinical diagnostics, David Carville (IVDT, Mar 2007, p. 31).
2006
- (Assay Development) Multiplexed microfluidic immunoassays for point-of-care in vitro diagnostics, Emil P. Kartalov (IVDT, Sep 2006, p. 55).
- (Assay Development) A multiplexed immunoassay for the rapid detection of specific IgE in allergy diagnosis, Mats Nystrand (IVDT, Jun 2006, p. 61).
- (Assay Development) Design considerations for immunodiagnostics, Bonnie J. Stewart, Raymond L. Houghton, WJW Morrow, and Syamal Raychaudhuri (IVDT, Apr 2006, p. 47).
- (Assay Development) A phased approach to the development and commercialization of new immunodiagnostic assays, Richard Taylor (IVDT, Mar 2006, p. 59).
- (Assay Development) A novel credit card–style assay for bedside determination of fatty acid–binding protein, "Cangel P. Y. Chan, Matthias Lehmann, Ilka Renneberg, Jürgen Ziegler, George W. H. Cautherley, Jan F. C. Glatz, and Reinhard Renneberg" (IVDT, Mar 2006, p. 51).
- (Assay Development) Present and future applications of gold in rapid assays, "James Carney, Helen Braven, Joanna Seal, and Emma Whitworth" (IVDT, Mar 2006, p. 41).
2005
- (Assay Development) Array analyses of human whole blood changes in protein fractions, James L. Schram Robert E. Pearson (IVDT, Nov 2005, p. 49). Keywords: New Technology.
- (Assay Development) Calibration of an immunochemical assay for a new biological marker, David Sogin (IVDT, Sep 2005, p. 51).
- (10th Anniversary Essays) 3. Assay development, Kevin D. Jones Klaus Hochleitner (IVDT, Apr 2005, p. 52). Keywords: New Technology.
- (Assay Development) Statistical practices in assay development and validation, Anastasia N. Derzko (IVDT, Mar 2005, p. 45). Keyword: Industry.
- (Assay Development) Paramagnetic microparticles for optimized biological separations, "Debra A. Sesholtz, Michael T. Gore" "Robert L. Frescatore, Kim M. Stever" (IVDT, Mar 2005, p. 39). Keyword: Industry.
2004
- (Assay Development) A genotype assay for the genetic determination of osteoporosis, Ken Milne (IVDT, Mar 2004, p. 53). Keyword: Industry.
- (Assay Development) A new brain - Sidebar, Svetlana A. Dembinova (IVDT, Mar 2004, p. 44). Keyword: Industry.
- (Assay Development) A new brain marker for laboratory assessment of TIA and stroke, Svetlana A. Dembinova (IVDT, Mar 2004, p. 43). Keyword: Industry.
2003
- (Assay Development) New life for a diagnostic reagent mainstay, Michael O. Budnick Randal S. Fitzgerald (IVDT, Jun 2003, p. 45). Keywords: New Technology.
- (Assay Development) Fluorescent Dextran Conjugates for use in Quantitive Assays, Tina Meyer Hansen (IVDT, Apr 2003, p. 35). Keyword: Industry.
- Enchancing Risk Assessment, Jeanne Ohrenberger (IVDT, Mar 2003, p. 35). Keywords: New Technology.
- Smaller is Better, John L. Tonkinson, Dan S. Osborn Brett A. Stillman, Weiwen Zhao (IVDT, Mar 2003, p. 29). Keywords: New Technology.
2002
- Testing urine for drugs of abuse, Alan Wu (IVDT, Jul 2002, p. 57).
- Gradient-gel electrophoresis in the clinical evaluation of heart disease risk, Ahn Le (IVDT, May 2002, p. 41).
- Duck antibodies for IVD applications, Victor Chiou (IVDT, Apr 2002, p. 31).
- (Assay Development) Immunogold conjugation for IVD applications, Nikki Robinson (IVDT, Mar 2002, p. 33).
